OTCQB: LXXGF | TSX.V: LXG

  • Company
    • Our Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
    • Join Our Team
    • News Releases
    • In the Media
    • Upcoming Events
  • Investors
    • Presentations
    • Financials
    • Share Structure
    • Stock Information
    • Investor Events
    • Investor Inquiries
  • Markets
    • Biologics Manufacturing
    • Veterinary Diagnostics
  • Products
    • MiQLab® System
    • Assay Panels
    • Request Product Information
    • I’d Like a Demonstration
  • Resources
  • Our Blog
  • Contact
    • Contact
    • Investor Inquiries
    • Support
    • Product Information
    • Subscribe for Updates
PCR Testing: The Gold Standard for Companion Animals

PCR Testing: The Gold Standard for Companion Animals

by Gail Winslow | Jan 20, 2022 | Veterinary Diagnostics

Learn more about the MiQLab solution offering in-clinic point-of-care veterinary diagnostic testing in ~2 hours addressing more than 50 percent of companion animal vet visits and increasing satisfaction.

Microbial QC Testing in the Manufacture of Biopharmaceuticals

Microbial QC Testing in the Manufacture of Biopharmaceuticals

by Dr Diane Stewart | Nov 18, 2021 | Biologics Manufacturing

Contamination control of bioprocessing cell lines is essential. The same environments that encourage desirable microbiological growth also encourage growth of undesirable contaminants including yeasts, molds, mycoplasma, bacteria, and viruses.

Point-of-Care qPCR Applications in Companion Animal Medicine

Point-of-Care qPCR Applications in Companion Animal Medicine

by Dr. Manoj Nair | Nov 18, 2021 | Veterinary Diagnostics

Improvements in qPCR testing are bringing point-of-care molecular diagnostics into practical use.

Modernizing Point-of-Care Diagnostics

Modernizing Point-of-Care Diagnostics

by Dr Jack Regan | Nov 18, 2021 | Human Clinical Diagnostics

Pandemic containment in the United States has proved ineffective due to a lack of preparation and deployment of modern pathogen-detection technologies. Improved point-of-care molecular diagnostics will save lives when the next pandemic emerges.

Press Releases

  • Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology May 25, 2022
  • The Dawn of the Superbugs May 10, 2022
  • LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility April 7, 2022
  • Bacterial Culture: Is It Time to Rethink the Gold Standard? March 28, 2022
  • Antimicrobial Resistance: The Human and Animal Connection March 17, 2022

Categories

  • Biologics Manufacturing
  • Biothreat Detection
  • Human Clinical Diagnostics
  • Investor Information
  • Product Information
  • Veterinary Diagnostics
  • Contact
  • Support
  • Privacy
  • Terms
  • Site Map

500 Cummings Ctr., Suite 4550 Beverly, MA 01915 USA
info@lexagene.com | 800.215.1824

Subscribe for Updates
  • Follow
  • Follow
  • Follow
  • Follow

©2022 LexaGene All Rights Reserved